RDInvesting Provides Investors with Free In-Depth Equity Reports on HOG, KORS, NTAP and NUVA
Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://www.rdinvesting.com/ and get exclusive access to our numerous stock reports and market updates.
Harley-Davidson, Inc. (NYSE: HOG) shares declined 0.93 percent to close at $55.44 a share Monday. The stock traded between $54.88 and $55.79 on volume of 1.65 million shares traded. Analysts at Wedbush have downgraded the company’s rating to “neutral” from “outperform”. Shares of Harley-Davidson have gained approximately 13.5 percent year-to-date.
Find out more about Harley-Davidson including full access to the free equity report at:
www.RDInvesting.com/HOG
Michael Kors Holdings Ltd. (NYSE: KORS) shares declined 1.83 percent to close at $62.65 a share Monday. The stock traded between $61.81 and $62.81 on volume of 3.67 million shares traded. Analysts at Piper Jaffray have downgraded the company’s rating to “neutral” from “overweight”. Shares of Michael Kors have gained approximately 22.7 percent year-to-date.
Find out more about Michael Kors including full access to the free equity report at:
www.RDInvesting.com/KORS
NetApp Inc. (NASDAQ: NTAP) shares gained 2.04 percent to close at $40.10 a share Monday. The stock traded between $39.85 and $40.48 on volume of 9.42 million shares traded. Analysts at Morgan Stanley have upgraded the company’s rating to “overweight” from “equal weight”. Shares of NetApp have gained approximately 19.5 percent year-to-date.
Find out more about NetApp including full access to the free equity report at:
www.RDInvesting.com/NTAP
NuVasive, Inc. (NASDAQ: NUVA) shares declined 1.09 percent to close at $26.41 a share Monday. The stock traded between $25.52 and $26.58 on volume of 531,143 shares traded. Analysts at BMO Capital have downgraded the company’s rating to “underperform” from “market perform”. Shares of NuVasive have gained approximately 70.8 percent year-to-date.
Find out more about NuVasive including full access to the free equity report at:
www.RDInvesting.com/NUVA
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
info@rdinvesting.com